Journal of Endocrinological Investigation

, Volume 17, Issue 9, pp 717–722 | Cite as

Relationship between hypophyseal portal GHRH and somatostatin and peripheral GH levels in the conscious sheep

  • M. Cataldi
  • E. Magnan
  • V. Guillaume
  • A. Dutour
  • B. Conte-Devolx
  • G. Lombardi
  • C. Oliver


The mechanisms involved in the genesis of pulsatile GH secretion are not well understood. Recently, methods for hypophyseal portal blood collection in conscious sheep became available. Using this method, GHRH and SRIH secretion into hypophyseal portal blood (HPB) and GH release from the pituitary gland were simultaneous assessed and the relationship between GHRH and SRIH changes in HPB and GH in peripheral blood was investigated. In 23 rams (9–11 month old, 35–45 kg bw), 126 hours of HPB were analysed. Fifty-four spontaneous GH peaks were detected. The majority of GH peaks (48.1%) was associated with an increased portal GHRH and a fall in somatostatin concentrations. A simultaneous increase in GHRH and somatostatin levels was observed in 18.5% of GH peaks while 12.9% of peaks occurred with a fall in SRIH and no modification in GHRH concentrations. Finally, 5/54 (9.3%) GH peaks occurred without any modification in portal GHRH and SRIH release. Our data indicate that the GHRH/SRIH interplay is complex. The occurrence of spontaneous GH peaks may be due not only to a coordinate increase in GHRH and reduction in SRIH release similar to male rat, but also to other patterns of GHRH/SRIH secretion.


GHRH somatostatin GH secretion hypophyseal portal blood 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Müller E.E. Neural control of somatotropic function. Physiol. Rev. 67: 962, 1987.PubMedGoogle Scholar
  2. 2.
    Tannenbaum G.S. Neuroendocrine control of growth hormone secretion. Acta Paediatr. Scand. (Supp.) 372: 5, 1991.CrossRefGoogle Scholar
  3. 3.
    Clark R.G., Jansson J.O., Isaksson O., Robinson I.C.A.F. Intravenous growth hormone: growth responses to patterned infusions in hypophysectomised rats. J. Endocrinol. 104: 53, 1985.PubMedCrossRefGoogle Scholar
  4. 4.
    Isgaard J., Carlsson L., Isaksson O.G., Jansson J.O. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology 123: 2605, 1988.PubMedCrossRefGoogle Scholar
  5. 5.
    Tannenbaum G.S., Ling N. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in the generation of the ultradian rhythm of GH secretion. Endocrinology 115: 1952, 1984.PubMedCrossRefGoogle Scholar
  6. 6.
    Plotsky P.M., Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science 230: 461, 1985.PubMedCrossRefGoogle Scholar
  7. 7.
    Tannenbaum G.S., Martin J.B. Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology 98: 562, 1976.PubMedCrossRefGoogle Scholar
  8. 8.
    Eden S. Age and sex related differences in episodic growth hormone secretion in the rat. Endocrinology 105: 555, 1979.PubMedCrossRefGoogle Scholar
  9. 9.
    Finkelstein J.A., Roffwarg H.P., Boyar R.M., Kream J., Hellman L. Age related changes in the twenty four hour spontaneous secretion of growth hormone. J. Clin. Endocrinol. Metab. 35: 665, 1972.PubMedCrossRefGoogle Scholar
  10. 10.
    Wehrenberg W.B., Brazeau P., Luben R., Bohlen P., Guillemin R. Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology 111: 2147, 1982.PubMedCrossRefGoogle Scholar
  11. 11.
    Sato M., Takahara J., Fujioka Y., Niimi M., Irino S. Physiological role of growth hormone (GH)-releasing factor and somatostatin in the dynamics of GH secretion in adult male rat. Endocrinology 123: 1928, 1988.PubMedCrossRefGoogle Scholar
  12. 12.
    Vance M.L., Kaiser D.L., Evans W.S., Furlanetto R., Vale W., Rivier J., Thorner M.O. Pulsatile growth hormone secretion in normal man during a continuous 24 hour infusion of human growth hormone releasing factor (1–40). J. Clin. Invest. 75: 1584, 1985.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Hindmarsh P.C., Brain C.E., Robinson I.C.A.F., Matthews D.R., Brook C.G.D. The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man. Clin. Endocrinol. (Oxf.) 35: 353, 1991.CrossRefGoogle Scholar
  14. 14.
    Laurentie M.P., Barenton B., Charrier J., Garcia-Villar R., Marnet P.G., Blanchard M.B., Toutain P.L. Instantaneous secretion rate of growth hormone in lambs: relationships with sleep, food intake, and posture. Endocrinology 125: 642, 1989.PubMedCrossRefGoogle Scholar
  15. 15.
    Frohman L.A., Downs T.R., Clarke I.J., Thomas G.B. Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia. J. Clin. Invest. 86: 17, 1990.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Thomas G.B., Cummins J.T., Francis H., Sudbury A.W., Mc Cloud P.I., Clarke I.J. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes. Endocrinology 128: 1151, 1991.PubMedCrossRefGoogle Scholar
  17. 17.
    Magnan E., Cataldi M., Guillaume V., Mazzocchi L., Dutour A., Conte-Devolx B., Giraud P., Oliver C. Neostigmine stimulates Growth Hormone-Releasing Hormone release into hypophysial portal blood of conscious sheep. Endocrinology 132: 1247, 1993.PubMedGoogle Scholar
  18. 18.
    Locatelli A., Caraty A. Approche transnasale du systeme porte hypophysaire chez le bélier: application à l’étude des neurosécrétions. Sci. Tech. Anim. Lab. 12: 185, 1987.Google Scholar
  19. 19.
    Oerter K.E., Guardabasso V., Rodbard D. Detection and characterisation of peaks and estimation of instantaneous secretory rate for episodic pulsatile hormone secretion. Comput. Biomed. Res. 19: 170, 1986.PubMedCrossRefGoogle Scholar
  20. 20.
    Burger H.G., Lee V.W.K., Rennie G.C. A generalized computer program for the treatment of data from competitive protein-binding assays including radioimmunoassays. J. Lab. Clin. Med. 80: 302, 1972.PubMedGoogle Scholar
  21. 21.
    Millard W.J., Martin J.B.Jr., Audet J., Sagar S.M., Martin J.B. Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 110: 540, 1982.PubMedCrossRefGoogle Scholar
  22. 22.
    Tannenbaum G.S., Eikelboom R., Ling N. Human pancreas GH-releasing factor analog restores high-amplitude GH pulses in CNS lesion-induced GH deficiency. Endocrinology 113: 1173, 1983.PubMedCrossRefGoogle Scholar
  23. 23.
    Jaffe C.A., De Mott Friberg R., Barkan A.L. Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GH-RH) antagonist. Direct evidence for involvement of endogenous GH-RH in the generation of GH pulses. J. Clin. Invest. 92: 695, 1993.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Cowan J.S., Moor B., Chow A., Kraicer J. Characterization of the post-somatostatin rebound in growth hormone secretion from perifused somatotrophs. Endocrinology 113: 1056, 1983.PubMedCrossRefGoogle Scholar
  25. 25.
    Kraicer J., Cowan J.S., Sheppard M.S., Lussier B., Moor B.C. Effect of somatostatin withdrawal and growth hormone (GH)-releasing factor on GH release in vitro: amount available for release after disinhibition. Endocrinology 119: 2047, 1986.PubMedCrossRefGoogle Scholar
  26. 26.
    Clark R.G., Carlsson L.M.S., Rafferty B., Robinson I.C.A.F. The rebound release of growth hormone (GH) following somatostatin infusion in rats involves hypothalamic GH-releasing factor release. J. Endocrinol. 119: 397, 1988.PubMedCrossRefGoogle Scholar
  27. 27.
    Magnan E., Cataldi M., Guillaume V., Conte-Devolx B., Graziani N., Figaroli J.C., Thomas F., Chihara K., Oliver C. Acute changes in growth hormone-releasing hormone secretion after injection of BIM 23014, a long acting somatostatin analog, in rams. Life Sci 51: 831, 1992.PubMedCrossRefGoogle Scholar
  28. 28.
    Epelbaum J., Moyse E., Tannenbaum G.S., Kordon C., Beaudet A. Combined autoradiographic and immunohistochemical evidence for an association of somatostatin binding sites with growth hormone-releasing factor-containing nerve cell bodies in the rat arcuate nucleus. J. Neuroendocrinol. 1: 109, 1989.PubMedCrossRefGoogle Scholar
  29. 29.
    Davis S.L. Somatostatin: its influence on plasma levels of growth hormone, prolactin and thyrotropin in sheep. J. Anim. Sci 40: 911, 1975.PubMedGoogle Scholar
  30. 30.
    Bass J.J., Gluckman P.D., Fairclough R.J., Peterson A.J., Davis S.R., Carter W.D. Effect of nutrition and immunization against somatostatin on growth and insulin-like growth factors in sheep. J. Endocrinol. 112: 27, 1987.PubMedCrossRefGoogle Scholar
  31. 31.
    Van Kessel A.G., Laarveld B. Acute or chronic immunoneutralization of somatostatin does not affect growth hormone or thyroid hormone secretion in sheep. J. Endocrinol. 136: 261, 1993.PubMedCrossRefGoogle Scholar
  32. 32.
    Law G.J., Ray K.P., Wallis M. Effects of growth hormone-releasing factor and somatostatin on growth hormone secretion and cellular cyclic AMP levels. Cultured ovine and rat anterior pituitary cells show markedly different responses. FEBS Lett. 179: 12, 1985.PubMedCrossRefGoogle Scholar
  33. 33.
    Stewart J.K., Clifton D.K., Koerker D.J., Rogol A.D., Jaffe T., Goodner C.J. Pulsatile release of growth hormone and prolactin from the primate pituitary in vitro. Endocrinology 116: 1, 1985.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1994

Authors and Affiliations

  • M. Cataldi
    • 1
  • E. Magnan
    • 1
  • V. Guillaume
    • 1
  • A. Dutour
    • 1
  • B. Conte-Devolx
    • 1
  • G. Lombardi
    • 2
  • C. Oliver
    • 1
  1. 1.INSERM U 297, Institut Fédératif Jean Roche, Faculté de Médecine NordLaboratoire de Neuroendocrinologie ExpérimentaleMarseille Cedex 20France
  2. 2.Istituto di EndocrinologiaNapoliItaly

Personalised recommendations